Pricing Log in Create free account
Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue
+19.2%
EPS
+64.1%
Free cash flow
−29.8%
Total debt
−5.19%

Quarter to September 2026, against a year earlier

145.23 10.89 −6.98%
Market cap
$10.8B
P/E
25.2×
Fwd P/E
24.4×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Insulet Corporation (PODD) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Insulet Corporation (PODD) trades at a EV/Sales of 3.5×. Over the past ten years it has ranged from 3.0× (September 2026) to 21.5× (November 2021); the current reading is higher than 2% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.5× (17.34%)
FY2024 9.0× 0.26%
FY2023 9.0× (42.87%)
FY2022 15.8× (6.26%)
FY2021 16.8× (8.63%)
FY2020 18.4× 24.88%
FY2019 14.8× 66.48%
FY2018 8.9× (1.02%)
FY2017 9.0× 49.59%
FY2016 6.0× (28.86%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.0× (17.68%)
Jun 2026 3.6× (31.26%)
Mar 2026 5.2× (30.07%)
Dec 2025 7.5× (14.30%)
43 more quarters

Against its own ten years

Low 3.0× High 21.5×
Ten-year median 9.7×
Current reading's percentile 2

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
BRKR Bruker Corporation compare 3.0×
PODD Insulet Corporation 3.5×
GMED Globus Medical, Inc. compare 3.5×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. compare 7.7×
TXG 10x Genomics compare 11.5×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PODD